Resultats de la cerca - David Mauro

  • Mostrar 1 - 9 resultats de 9
Refinar resultats
  1. 1
    Superior mesenteric vein injury in penetrating abdominal trauma: Case report and a literature review

    Superior mesenteric vein injury in penetrating abdominal trauma: Case report and a literature review per David Mauro, Byron Miyazawa, Sílvia Nascimento, Telma Alves, Joao Gabriel Nogueira Scorpione

    Publicat 2024
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma

    A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma per Shawn Yu, Menggang Yu, Barry Keane, David Mauro, Paul R. Helft, William Proctor Harris, Hanna K. Sanoff, Matthew S. Johnson, Bert H. O’Neil, Autumn J. McRee, Ashwin Somasundaram

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumors

    A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tum... per Manik Amin, Susan Minton, Patricia LoRusso, Smitha Krishnamurthi, Cheryl A. Pickett, Jared Lunceford, Darcy A. Hille, David Mauro, Mark N. Stein, Andrea Wang‐Gillam, Lauren Trull, A. Craig Lockhart

    Publicat 2015
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma

    Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma per Antoni Ribas, Theresa Medina, John M. Kirkwood, Yousef Zakharia, René González, Diwakar Davar, Bartosz Chmielowski, Katie M. Campbell, Riyue Bao, Heather Kelley, Aaron J. Morris, David Mauro, James E. Wooldridge, Jason J. Luke, George J. Weiner, Arthur Μ. Krieg, Mohammed Milhem

    Publicat 2021
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma

    A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma per Peter M. Anderson, Stefan Bielack, Richard Görlick, Keith M. Skubitz, Najat C. Daw, Cynthia E. Herzog, Odd R. Monge, Álvaro Lassaletta, Érica Boldrini, Zsuzanna Pápai, Joseph Rubino, Kumudu Pathiraja, Darcy A. Hille, Mark Ayers, Siu‐Long Yao, Michael Nebozhyn, Brian Lu, David Mauro

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose

    Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose per Christine H. Chung, Beloo Mirakhur, Emily Chan, Quynh‐Thu Le, Jordan Berlin, Michael A. Morse, Barbara A. Murphy, Shama M. Satinover, Jacob D. Hosen, David Mauro, Robbert J.C. Slebos, Qinwei Zhou, Diane R. Gold, Tina Hatley, Daniel J. Hicklin, Thomas A.E. Platts‐Mills

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    A Phase 1 Escalating Single-Dose and Weekly Fixed-Dose Study of Cetuximab: Pharmacokinetic and Pharmacodynamic Rationale for Dosing

    A Phase 1 Escalating Single-Dose and Weekly Fixed-Dose Study of Cetuximab: Pharmacokinetic and Pharmacodynamic Rationale for Dosing per Paula M. Fracasso, Howard A. Burris, Matthew A. Arquette, Ramaswamy Govindan, Feng Gao, L. Wright, Sherry A. Goodner, F. Anthony Greco, Suzanne F. Jones, Noel T. Willcut, Catherine Chodkiewicz, Amit Pathak, Gregory M. Springett, George R. Simon, Daniel M. Sullivan, Raphaël Marcelpoil, S. Mayfield, David Mauro, Christopher R. Garrett

    Publicat 2007
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    MCL1 and BCL-xL Levels in Solid Tumors Are Predictive of Dinaciclib-Induced Apoptosis

    MCL1 and BCL-xL Levels in Solid Tumors Are Predictive of Dinaciclib-Induced Apoptosis per Robert N. Booher, Harold Hatch, Brian Dolinski, Thi Phuong Nguyen, Lauren Harmonay, Ali-Samer Al-Assaad, Mark Ayers, Michael Nebozhyn, Andrey Loboda, Heather A. Hirsch, Theresa Zhang, Bin Shi, C. Merkel, Minilik Angagaw, Yaolin Wang, Brian J. Long, Xianlu Q. Lennon, Nathan R. Miselis, Vincenzo Pucci, James W. Monahan, Junghoon Lee, Anna Kondic, Eun Kyung Im, David Mauro, Rebecca Blanchard, Gary Gilliland, Stephen E. Fawell, Leigh Zawel, Alwin G. Schuller, Peter R. Strack

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial

    Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial per Diwakar Davar, Robert M. Morrison, Amiran Dzutsev, Arivarasan Karunamurthy, Joe-Marc Chauvin, F. Amatore, Julie S. Deutsch, Rodrigo X. Das Neves, Richard R. Rodrigues, John A. McCulloch, Hong Wang, Douglas J. Hartman, Jonathan H. Badger, Miriam R. Fernandes, Yulong Bai, Jie Sun, Alicia M. Cole, Poonam Aggarwal, Jennifer R. Fang, Christopher Deitrick, Riyue Bao, Umamaheswar Duvvuri, Shaum Sridharan, Seungwon Kim, Haroon A. Choudry, Matthew P. Holtzman, James F. Pingpank, James Patrick O'Toole, Richelle DeBlasio, Yang Jin, Quanquan Ding, Wentao Gao, Christopher Groetsch, Ornella Pagliano, Amy Rose, Corey Urban, Jagjit Singh, Prajan Divarkar, David Mauro, Dmitri Bobilev, James E. Wooldridge, Arthur Μ. Krieg, Matthew G. Fury, Jeffrey R. Whiteaker, Lei Zhao, Amanda G. Paulovich, Yana G. Najjar, Jason J. Luke, John M. Kirkwood, Janis M. Taube, Hyun Jung Park, Giorgio Trinchieri, Hassane M. Zarour

    Publicat 2024
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: